A male patient visited our hospital for evaluation of a pancreatic cystic tumor. Although he had a history of regular alcohol consumption, he had been previously well. Laboratory examination revealed normal serum levels of amylase, lipase, carbohydrate antigen 19-9, and carcinoembryonic antigen. On computed tomography, a mass lesion, 30 mm in diameter, was detected in the pancreatic body \[[Figure 1](#F1){ref-type="fig"}\]. Magnetic resonance cholangiopancreatography showed a cystic tumor and that the main pancreatic duct was not dilated \[[Figure 2](#F2){ref-type="fig"}\]. Moreover, EUS showed a multilocular cystic lesion suspected as having central scar \[[Figure 3](#F3){ref-type="fig"}\]. On contrast-enhanced EUS using Sonazoid^®^, strong enhancement was observed in the scar \[[Video 1](#SD1){ref-type="supplementary-material"}\]. First, we suspected this lesion of serous cystic tumor of the pancreas. EUS-FNA biopsy of the central scar was performed using a 22-gauge needle and revealed that the lesion was adenocarcinoma \[[Video 2](#SD2){ref-type="supplementary-material"}\]. Hence, we performed surgical treatment. Histopathologically, the cystic lesion was diagnosed as a retention cyst, and adenocarcinoma was located in the scar \[Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}\]. Finally, he was diagnosed with pancreatic ductal adenocarcinoma.

![Abdominal computed tomography revealed a tumor, 30 mm in diameter, in the pancreatic body](EUS-7-212-g001){#F1}

![Magnetic resonance cholangiopancreatography showed a cystic tumor, with no dilation of the pancreatic duct](EUS-7-212-g002){#F2}

![Endoscopic ultrasonography showed a multiloculated cystic lesion, which seemed to have a central scar](EUS-7-212-g003){#F3}

![Histopathologically, this cystic lesion was diagnosed as a retention cyst](EUS-7-212-g004){#F4}

![As preoperatively suspected, the central scar was demonstrated to be an adenocarcinoma](EUS-7-212-g005){#F5}

Despite advances in imaging techniques, the differential diagnosis of a pancreatic cystic tumor is sometimes challenging. Several methods such as fluid analysis under EUS-FNA have been reported.\[[@ref1][@ref2]\] Although EUS-FNA for a cystic tumor of the pancreas can lead to dissemination of the tumors,\[[@ref3]\] the procedure is recommended to avoid misdiagnosis, provided it can be safely performed while avoiding the cystic components such as our case.
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